Search Results - Fricke, Stephanie L

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific

    HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific by Evans, 3rd, Edward L, Becker, Jordan T, Fricke, Stephanie L, Patel, Kishan, Sherer, Nathan M

    Published in Journal of virology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

    MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers by Fricke, Stephanie L, Payne, Susan N, Favreau, Peter F, Kratz, Jeremy D, Pasch, Cheri A, Foley, Tyler M, Yueh, Alexander E, Van De Hey, Dana R, Depke, Mitchell G, Korkos, Demetra P, Sha, Gioia Chengcheng, DeStefanis, Rebecca A, Clipson, Linda, Burkard, Mark E, Lemmon, Kayla K, Parsons, Benjamin M, Kenny, Paraic A, Matkowskyj, Kristina A, Newton, Michael A, Skala, Melissa C, Deming, Dustin A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract B27: MTORC1/2 inhibition as a treatment strategy for PIK3CA mutant colorectal cancer

    Abstract B27: MTORC1/2 inhibition as a treatment strategy for PIK3CA mutant colorectal cancer by DeStefanis, Rebecca A., Payne, Susan N., Miller, Devon, Pasch, Cheri A., Babiarz, Christopher, DeZeeuw, Alyssa, Fricke, Stephanie L., Sprackling, Carley, Yueh, Alexander E., Korkos, Demetra P., Van De Hey, Dana R., Sha, Gioia, Greane, Aurora, Kratz, Jeremy D., Clipson, Linda, Matkowskyj, Kristina A., Newton, Michael A., Deming, Dustin A.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 2936: MTORC1/2 inhibition in combination with BCL-2/BCL-xL inhibition in APC and PIK3CA mutant colorectal cancer

    Abstract 2936: MTORC1/2 inhibition in combination with BCL-2/BCL-xL inhibition in APC and PIK3CA mutant colorectal cancer by Fricke, Stephanie L., Payne, Susan N., Pasch, Cheri A., Korkos, Demetra P., Sha, Gioia, Yueh, Alex E., Babiarz, Christopher, Clipson, Linda, Matkowskyj, Kristina A., Newton, Michael A., Deming, Dustin A.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination

    Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination by Paniskaki, Krystallenia, Anft, Moritz, Meister, Toni L, Marheinecke, Corinna, Pfaender, Stephanie, Skrzypczyk, Sarah, Seibert, Felix S, Thieme, Constantin J, Konik, Margarethe J, Dolff, Sebastian, Anastasiou, Olympia, Holzer, Bodo, Dittmer, Ulf, Queren, Christine, Fricke, Lutz, Rohn, Hana, Westhoff, Timm H, Witzke, Oliver, Stervbo, Ulrik, Roch, Toralf, Babel, Nina

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    From chemosensory thresholds to whole body exposures : experimental approaches evaluating chemosensory effects of chemicals

    From chemosensory thresholds to whole body exposures : experimental approaches evaluating chemosensory effects of chemicals by VAN THRIEL, Christoph, SCHÄPER, Michael, KIESSWETTER, Ernst, KLEINBECK, Stefan, JURAN, Stephanie, BLASZKEWICZ, Meinolf, FRICKE, Hajo-Hennig, ALTMANN, Lilo, BERRESHEIM, Hans, BRÜNING, Thomas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener’s granulomatosis

    A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener’s granulomatosis by Wieczorek, Stefan, Holle, Julia U., Müller, Stephanie, Fricke, Harald, Gross, Wolfgang L., Epplen, Jörg T.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: